MFSI

MicroFluidic Systems (MFSI) is a biotechnology company that specializes in the development of microfluidic systems for automated sample preparation and biological assays. Founded in 2001 by M. Allen Northrup, a co-founder of Cepheid, the company is recognized for developing the world's first miniaturized, portable, battery-operated, real-time PCR-based detection system. MFSI's core technology focuses on DNA-based pathogen detection, serving both the U.S. government for homeland security and the commercial healthcare market for rapid medical testing. The company's intellectual property portfolio includes advanced microfluidic designs for processing complex biological samples. In 2011, MFSI was acquired by PositiveID Corporation to integrate its rapid diagnostic capabilities into PositiveID's healthcare and virus detection portfolio.